A total of 75.8% (213 of 281) of mutations detected in patient L4 TB at progression was found in GR-CDXL4 CDX, including loss-of-function in tumor suppressor genes RB1, TP53, and NF1 (Figure 3A). The gene discussed is RB1; the disease is tuberculosis.